Skip to main content
Hanmi Science Co.,Ltd logo

Hanmi Science Co.,Ltd — Investor Relations & Filings

Ticker · 008930 ISIN · KR7008930000 KO Manufacturing
Filings indexed 702 across all filing types
Latest filing 2026-06-02 Major Shareholding Noti…
Country KR South Korea
Listing KO 008930

About Hanmi Science Co.,Ltd

https://www.hanmipharm.com/

Hanmi Science Co., Ltd. is a holding company that manages subsidiaries engaged in the pharmaceutical and healthcare sectors. Its principal operating subsidiary, Hanmi Pharmaceutical, is an R&D-centric biopharmaceutical company focused on the development of innovative new drugs. The group's integrated activities span from in-house research and development to the manufacturing and commercialization of a wide range of pharmaceutical products. A key strategic focus is the creation of novel therapies to address unmet medical needs, which are then provided to medical professionals.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 98% confidence The document is a detailed “주식등의 대량보유상황보고서” (Report on Large Shareholdings) filed under the Korean Capital Markets Act. It lists the reporting person, their related parties, share counts, ratios, ownership changes and major contracts (pledges, loans, repo agreements), which is exactly the Major Shareholding Notification. It is not an earnings release, proxy, or AGM material but a regulatory form for threshold‐crossing share ownership. Therefore it maps to Major Shareholding Notification (MRQ).
2026-06-02 Korean
기업지배구조보고서공시
Governance Information Classification · 87% confidence The document is a comprehensive corporate governance report (“기업지배구조보고서 신고서”) detailing board composition, governance policies, compliance with governance indicators, shareholder meeting procedures, and internal controls. This aligns exactly with the definition of Governance Information (CGR).
2026-06-01 Korean
투자판단관련주요경영사항(자회사의 주요경영사항) (소네페글루타이드 (Sonefpeglutide; LAPS GLP2 agonist; HM15912) 기술이전 계약 체결)
Regulatory Filings Classification · 92% confidence The document is a disclosure of a licensing contract (technology transfer agreement) by HanmiScience, outlining key terms such as upfront payment, milestones, royalties, contract parties and dates. It is not an annual or interim report, call transcript, management change, shareholder vote, dividend notice, or financial statements. It is a general regulatory announcement of a material contract, which falls into the fallback “Regulatory Filings” category (RNS).
2026-06-01 Korean
투자판단관련주요경영사항(자회사의 주요경영사항) (HCP18034 개발을 위한 식약처(MFDS) 제3상 임상시험 계획 승인)
Regulatory Filings Classification · 82% confidence The document is a KRX regulatory disclosure titled “투자판단 관련 주요경영사항” describing approval of a Phase III clinical trial by MFDS, intended as a material announcement for investors. It contains no financial statements or management discussion, nor is it announcing publication of a report. This fits the catch-all “Regulatory Filings” category for miscellaneous regulatory announcements (RNS).
2026-05-29 Korean
단일판매ㆍ공급계약체결(자회사의 주요경영사항)
Regulatory Filings Classification · 80% confidence The document is a regulatory announcement in Korean describing the company’s execution of a single sales and supply contract, including contract amount, counterpart, term, and related details. It does not constitute a financial report (e.g., 10-K, IR), nor does it fit into specific categories like M&A, share issuance, dividend notice, or board changes. Therefore, it falls under the general “Regulatory Filings” fallback category (RNS).
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 99% confidence The document is a detailed quarterly report (“분기보고서”) for the period January 1 to March 31, 2026, containing extensive financial statements, segment disclosures, production and sales data, and notes. It is the actual interim/quarterly report, not merely an announcement or summary. This matches the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.